Advisor Group Holdings, Inc. Ngm Biopharmaceuticals Inc Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$3.72 - $5.4 $174 - $253	47 Added 146.88%	79 $0
Q4 2022 Feb 10, 2023	BUY	$3.41 - $12.93 $109 - $413	32 New	32 $0
Q3 2020 Nov 12, 2020	SELL	$15.59 - $19.97 $1,559 - $1,997	-100 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$11.97 - $23.47 $1,197 - $2,347	100 New	100 $2,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.